---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-002269"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2022-01-07T23:59:59+00:00"
generated_at: "2026-06-27T19:53:34.457675+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics CFO Joseph Vazzano resigns; CEO Lucy Lu appointed interim CFO

## Summary
- Joseph Vazzano resigns as CFO effective Jan 14, 2022, to pursue other opportunities; no disagreement with company.
- Vazzano will transition to a consulting role under a consulting agreement dated Jan 7, 2022.
- Board appoints Dr. Lucy Lu, current President and CEO, as interim CFO and Principal Financial Officer.

## SEC filing metadata
- accession: 0001104659-22-002269
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2022-01-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465922002269/0001104659-22-002269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465922002269/tm221800d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-002269
- JSON: https://secwatch.observer/filing/0001104659-22-002269.json
- Plain text: https://secwatch.observer/filing/0001104659-22-002269.txt

## Key facts
- Executive change
  Joseph Vazzano departed as Chief Financial Officer at AVENUE THERAPEUTICS, INC..
  - Action: resigning
  - Role: Chief Financial Officer
  source text: Mr. Joseph Vazzano notified Avenue Therapeutics, Inc. (the “Company”) that he was resigning from his role as the Company’s Chief Financial Officer, effective January 14, 2022, to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465922002269/0001104659-22-002269-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.